Mdsim

Mdsim, founded in 2022 in Esch-sur-Alzette, Luxembourg, specializes in healthcare technology, particularly in spine surgery. The company has completed one deal to date.Mdsim specializes in advanced healthcare solutions centered around its flagship product, the SPINEsim Software-as-Medical Device Platform. This platform employs data, computer modeling, simulation, and artificial intelligence to create patient-specific biomechanical digital twins of the spine. The primary aim is to empower clinicians, particularly spine surgeons, and patients in assessing, preventing, and planning optimal surgical interventions for conditions such as aging, osteoporosis, scoliosis, trauma, and tumors that lead to spinal degeneration and deformity.Mdsim generates revenue primarily through subscriptions to its SPINEsim platform, targeting healthcare institutions and individual clinicians. Clients engage with the platform to access advanced simulation tools that assist in planning spine surgeries and tracking patient progress. The transaction structure is designed to foster long-term partnerships with medical professionals, allowing for ongoing access to the platform in exchange for a subscription fee. The company is focused on expanding its product offerings and aims to enhance the capabilities of its SPINEsim platform to meet the growing needs in spine care. Mdsim's strategic plans also include targeting expansion into new regions with a focus on healthcare markets in North America and Europe, aligning with the increasing demands for advanced spine healthcare solutions.

1. Seed

   Jan 31, 2025

   Amount

   $2.1M

   Investors

   Locked